R. P. Finger Et Al. , "Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems," BMC OPHTHALMOLOGY , vol.20, no.1, 2020
Finger, R. P. Et Al. 2020. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC OPHTHALMOLOGY , vol.20, no.1 .
Finger, R. P., Daien, V., Eldem, B. M., Talks, J. S., Korobelnik, J., Mitchell, P., ... Sakamoto, T.(2020). Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC OPHTHALMOLOGY , vol.20, no.1.
Finger, Robert Et Al. "Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems," BMC OPHTHALMOLOGY , vol.20, no.1, 2020
Finger, Robert P. Et Al. "Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems." BMC OPHTHALMOLOGY , vol.20, no.1, 2020
Finger, R. P. Et Al. (2020) . "Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems." BMC OPHTHALMOLOGY , vol.20, no.1.
@article{article, author={Robert P. Finger Et Al. }, title={Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems}, journal={BMC OPHTHALMOLOGY}, year=2020}